[Federal Register: March 15, 2002 (Volume 67, Number 51)]
[Rules and Regulations]               
[Page 11571]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr02-7]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 333

[Docket No. 96P-0460]

 
Topical Antifungal Drug Products for Over-the-Counter Human Use; 
Amendment of Final Monograph; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
rule that appeared in the Federal Register of February 8, 2002 (67 FR 
5942). The document amended the final monograph for over-the-counter 
(OTC) topical antifungal drug products to add the ingredient 
clotrimazole as generally recognized as safe and effective for the 
treatment of athlete's foot, jock itch, and ringworm. The document was 
inadvertently published with an incorrect docket number. This document 
corrects that error.

FOR FURTHER INFORMATION CONTACT: Doris B. Tucker, Office of Policy (HF-
27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
20857, 301-827-7010.
    In FR Doc. 02-3079, appearing on page 5942 in the Federal Register 
of Friday, February 8, 2002, the following correction is made:
    1. On page 5942, in the first column, ``[Docket No. 99N-4063]'' is 
corrected to read ``[Docket No. 96P-0460]''.

    Dated: March 7, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-6180 Filed 3-14-02; 8:45 am]
BILLING CODE 4160-01-S